NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Teaching moment about scrutinizing new screening tests: rein in the hype

Posted By


A journalist wrote to me last week urging us to review stories about a study making claims about a new colon cancer DNA screening test. The journalist called the news “PR-driven hooey.”

We looked closely at four stories on the study. We found them all lacking for a variety of reasons.

Links to the full reviews:

• Philadelphia Inquirer

• New York Times

• HealthDay

• WebMD

Among the problems we found among the four stories:

• failure to include any independent perspective and using only input from conflicted individuals (in fact one story included the comments of a conflicted researcher who admitted “I haven’t looked under the hood” at the new findings!);

• failure to establish how very preliminary were these findings and that the kind of study that was done tends to overestimate success;

• failure to report that the DNA test in question isn’t the only new test in development;

• cheerleading language from two stories referring to the search for “the Holy Grail” – one of them saying it “appears to be getting close”;

• emphasizing potential benefits and minimizing of potential harms – a common journalistic pitfall in reporting on screening tests;

• failure to give any meaningful data-backed comparison of the new test with existing colon cancer screening tests including other blood stool tests;

• inflated estimates of how many people don’t get colon cancer screening now – with one story saying only 40% do and another saying only 20% do. But the fact is that the CDC BRFSS survey estimates that about 60% of US adults are up to date with screening, most with colonoscopy. Why would journalists use such inflated estimates, except that they got their estimates from conflicted researchers who stand to gain in some way from promotion of these findings and this new test?

Over and over again we point out journalists’ failure to apply healthy skepticism to screening tests.

They seem hell-bent on promoting the search for weapons of mass destruction inside all of us.

More balance, more evaluation of evidence, more healthy skepticism is needed.

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.